Patent ID: 11883087
Assignee: MEDTRONIC IRELAND MANUFACTURING UNLIMITED COMPANY
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 10:
11. A method for treating a human patient with diagnosed systemic sympathetic overactivity, the method comprising:
transluminally delivering a neuromodulation element of a catheter to a renal artery or renal branch artery of the human patient;
delivering neuromodulation therapy to afferent and efferent renal nerves via the neuromodulation element, wherein delivering the neuromodulation therapy to afferent and efferent renal nerves includes selectively delivering the neuromodulation therapy to efferent renal nerves such that a greater percentage of efferent renal nerves are modulated relative to a percentage of modulated afferent renal nerves; and
removing the neuromodulation element and catheter from the human patient after treatment,
wherein selectively delivering the neuromodulation therapy to the efferent renal nerves improves a measurable physiological parameter associated with the systemic sympathetic overactivity of the human patient within three months to 12 months after treatment.